The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.
about
Functionalized fullerenes in photodynamic therapyTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesEfficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx.Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.The future of photodynamic therapy in oncology.Monitoring photodynamic therapy of head and neck malignancies with optical spectroscopies.Review on early technology assessments of nanotechnologies in oncology.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.Inventory of economic evaluation of head and neck oncology from the German perspective.Photodynamic therapy in the upper aerodigestive tract. Overview and outlook.Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.Chlorin e6 Conjugated Interleukin-6 Receptor Aptamers Selectively Kill Target Cells Upon Irradiation.Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells.Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells.Photodynamic Effect of Methylene Blue and Low Level Laser Radiation in Head and Neck Squamous Cell Carcinoma Cell Lines.
P2860
Q26851870-36AF23D2-F9FB-417D-BBFD-738BB640BF56Q28085631-AE670639-5618-4398-B37B-DF5CEE0B1D30Q34394997-55662C5C-CF26-4428-AC65-9520FF2A6859Q35952297-3EFC7402-0F0C-4D43-A53D-18367E97DA49Q36429669-ABE977F0-FD9B-4961-836C-D82484A62637Q37354626-4D99162B-CCCB-448B-847D-5531CA7318D2Q37525371-955A708D-7D51-44C7-BEA2-F5C517A4C69BQ37919156-3BAC782B-20E8-4B1A-9316-89F8F67AA9AFQ38176769-702D3ACB-9201-4E9D-AD42-2CB046EB1172Q38787155-736EB1BD-2F4C-4F3A-B7F9-4EC853FE8DFAQ38990039-19CB4573-EE1D-42BC-ACA8-60B9E3F5582AQ39259654-B403DD1B-E266-48E5-A1F8-9BA0614C95C9Q39994538-BA1ADCC0-4D06-42E3-8F7B-203723E93267Q40165974-AE033E16-ECC3-4550-A51E-D2333636D622Q55056131-7EA012DD-B56A-4428-B797-0F9322781608
P2860
The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The cost-effectiveness of Fosc ...... ead and neck cancer in the UK.
@ast
The cost-effectiveness of Fosc ...... ead and neck cancer in the UK.
@en
type
label
The cost-effectiveness of Fosc ...... ead and neck cancer in the UK.
@ast
The cost-effectiveness of Fosc ...... ead and neck cancer in the UK.
@en
prefLabel
The cost-effectiveness of Fosc ...... ead and neck cancer in the UK.
@ast
The cost-effectiveness of Fosc ...... ead and neck cancer in the UK.
@en
P2093
P1433
P1476
The cost-effectiveness of Fosc ...... ead and neck cancer in the UK.
@en
P2093
P304
P356
10.1016/J.ORALONCOLOGY.2003.09.003
P407
P577
2004-04-01T00:00:00Z